Edition

Saiqa Mullick

2

Articles

0

Comments

Director of Implementation Science, Wits Reproductive Health & HIV Institute, University of the Witwatersrand

NIAID

December 1, 2017

One year in: lessons on rolling out an HIV prevention pill in South Africa

Sinead Delany-Moretlwe, University of the Witwatersrand and Saiqa Mullick, University of the Witwatersrand

South Africa’s data rollout of its pre-exposure prophylaxis shows that there is a relatively slow, but increasing, uptake. However, more needs to be done to target young women.

South Africa’s successes in HIV treatment have been marred by challenges in improving HIV prevention methods. Reuters/Nacho Doce

December 1, 2015

South Africa has excelled in treating HIV – prevention remains a disaster

Willem Daniel Francois Venter, University of the Witwatersrand; Saiqa Mullick, University of the Witwatersrand, and Sinead Delany-Moretlwe, University of the Witwatersrand

With nearly one-fifth of the globe’s HIV positive population, South Africa has the largest anti-retroviral program in the world. But HIV prevention still presents a big challenge for the country.

Contact Saiqa for

General
Media request
Speaking request
Consulting / Advising
Research collaboration
Research supervision

Location: Johannesburg, South Africa
Article Feed
Joined November 30, 2015